Headline News

 

Pfizer’s BRAFTOVI regimen nearly doubles median progression free survival in metastatic colorectal cancer

Posted on June 01, 2026

Sanofi’s Venglustat accepted for priority review to treat type 3 Gaucher disease in the US

Posted on June 01, 2026

A single dose of Lilly’s VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia

Posted on May 25, 2026

Novo Nordisk presents new MASH data at EASL 2026

Posted on May 25, 2026

CHMP recommends approval of Wegovy 7.2 mg in a single dose pen, delivering up to 20.7% mean weight loss

Posted on May 25, 2026

BAXFENDY approvedas a first in class aldosterone synthase inhibitor for hypertension

Posted on May 25, 2026

DATROWAY approved as the first TROP2 directed antibody drug conjugate for first line treatment of patients with metastatic triple negative breast cancer who are not PD-1/PD-L1 inhibitor candidates

Posted on May 25, 2026

Allergan Aesthetics receives positive CHMP opinion for Boey in glabellar lines

Posted on May 25, 2026

AbbVie announces positive CHMP opinion for MAVIRET in acute hepatitis C

Posted on May 25, 2026

Bristol Myers Squibb announces strategic agreement with Anthropic to position Claude Enterprise as the shared intelligence platform across its global operations

Posted on May 25, 2026

Lilly’s retatrutide delivers powerful weight loss in pivotal Phase 3 obesity trial

Posted on May 25, 2026

Foundayo was linked to body weight reductions of up to 13% in adults aged 65 and older living with obesity or overweight, according to a new analysis of the ATTAIN-1 and ATTAIN-2 trials.

Posted on May 25, 2026

Regeneron strikes Helicon peptide pact with Parabilis to build new Antibody-Helicon Conjugate class

Posted on May 19, 2026

GSK’s Arexvy clears Japanese regulators for at-risk adults aged 18–59

Posted on May 19, 2026

European Commission expands Pfizer’s HYMPAVZI label to cover haemophilia A and B patients with inhibitors

Posted on May 19, 2026